Ensuring Patient Access to Critical Breakthrough Products Act

United States Congress · 119 session · house

HR 5343Ensuring Patient Access to Critical Breakthrough Products Act

Latest action: 2025-09-17 — Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Primary sponsor: Rep. Moore, Blake D. [R-UT-1] (R)

Health

Track this bill

Versions

Introduced in HouseSep 15, 2025

Legislative history

Sep 17, 2025

Committee Consideration and Mark-up Session Held

Sep 17, 2025

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

Sep 15, 2025

Introduced in House

Sep 15, 2025

Introduced in House

Sep 15, 2025

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sep 15, 2025

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Official sources

Version 0PDF HTML XML

About this page

Is this the official United States Congress bill page?: No — this is Billy’s public legislative record for HR 5343. Official source links are listed above when publishers provide them.
Can I track updates?: Yes. Sign in to track HR 5343, get alerts, annotate diffs, and export Word work product.

Sponsors

Versions

Legislative history

Official sources

About this page